Skip to content

Efficacy of Maitland Mobilization in Shoulder Pathology

Effec of Maitland in Shoulder Pathology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05030402
Enrollment
63
Registered
2021-09-01
Start date
2020-09-03
Completion date
2022-10-31
Last updated
2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinosis

Keywords

Shoulder, Maitland, Tendinosis

Brief summary

The shoulder is a mobile structure which generates a lot of pathologies. One of them is rotator cuff tendinosis. On the other hand, it has been investigated that Maitland is effective for reducing pain and for mobility in the cervical and lumbar spine and in joints such as the knee and ankle, however, there are few studies that confirm that it is effective in shoulder pathologies.So here the investigatprs want to study the effectiveness of Maitland as an adjunctive treatment for shoulder pathologies, comparing it with conventional physiotherapy treatment, in relation to the reduction of pain and increased mobility. For that the investigators have a randomized clinical trial with two group.

Detailed description

Group 1 receives tens, SW, conventional physiotherapy and exercises as treatment. Group 2 receives tens, SW, Mailtland, and exercises. An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Interventions

PROCEDUREMaitland

An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

PROCEDURETens, exercise, SW

An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

PROCEDUREConventional physiotherapy

An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Sponsors

University of Las Palmas de Gran Canaria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Have a shoulder pathology. * Have a restriction at least of two ranges of movement of the shoulder. * Sign the consent before starting the study.

Exclusion criteria

* Patients with a history of shoulder or neck surgery. * Patients with neurological damage such as stroke or disease of Parkinson's, as well as those with rheumatism, osteoporosis, surgical fixation, or malignant tumors. * Have a radiating pain in shoulder from a cervical injury. * Pregnant patients. * Patients who do not sign the consent before starting the study.

Design outcomes

Primary

MeasureTime frameDescription
Change of Range of Motion (ROM)Baseline and 1, 5, and 7 weeks after treatmentActive ROM of the affected shoulder is measured using a Mechanic Analysis to assess range of motion. These measurements included abduction, flexion, internal rotation, and external rotation.
Change of Visual Analog Scale (VAS)Baseline and 1, 5, and 7 weeks after treatmentVisual analogue score (VAS) was done at rest and at shoulder movement. VAS was explained to the patients during assessment as 0 equal no pain and 10 equal worst imaginable pain.
Change of Disabilities of the Arm, Shoulder and Hand (DASH)Baseline and 1, 5, and 7 weeks after treatmentDisabilities of the Arm, Shoulder and Hand (DASH) was filled by patient during assessment as 0 equal better functionality and 100 equal worst functionality

Secondary

MeasureTime frameDescription
Change of American shoulder and elbow Surgeons (ASES)Baseline and 1, 5, and 7 weeks after treatmentDisabilities of the Arm, Shoulder and Hand (DASH) was filled by patient during assessment as 0 equal worst functionality and 100 is equal better functionality
Change of 36-Item Health Survey (SF-36)Baseline and 1, 5, and 7 weeks after treatmentHealth Survey (SF-36) was filled by patient during assessment as 0 equal worst health and 100 is equal better health

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026